Clinical trial
The Effects of Rosiglitazone on Cognition in Patients With MCI
NCT00242593 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Rosiglitazone on Cognition in Patients With MCI
- Lead sponsor
- University of Washington
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2006
- Completion date
- December 31, 2011
- Enrollment
- 120 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
mild cognitive impairment